Amoy Diagnostics Co Ltd
SZSE:300685
Amoy Diagnostics Co Ltd
Revenue
Amoy Diagnostics Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amoy Diagnostics Co Ltd
SZSE:300685
|
Revenue
¥1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Revenue
¥9.6B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Revenue
¥6.2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
266%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Revenue
¥5.5B
|
CAGR 3-Years
33%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Revenue
¥7.6B
|
CAGR 3-Years
41%
|
CAGR 5-Years
32%
|
CAGR 10-Years
27%
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Revenue
¥49.7B
|
CAGR 3-Years
53%
|
CAGR 5-Years
65%
|
CAGR 10-Years
50%
|
See Also
What is Amoy Diagnostics Co Ltd's Revenue?
Revenue
1B
CNY
Based on the financial report for Dec 31, 2023, Amoy Diagnostics Co Ltd's Revenue amounts to 1B CNY.
What is Amoy Diagnostics Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
19%
Over the last year, the Revenue growth was 24%. The average annual Revenue growth rates for Amoy Diagnostics Co Ltd have been 13% over the past three years , 19% over the past five years .